Strax

Autospela

Dr. Ai on the Efficacy of Brentuximab Vedotin in Patients With Advanced Cutaneous T-Cell Lymphoma

5 Visningar • 08/09/23
Dela med sig
Bädda in
administrator
administrator
Prenumeranter
0

Weiyun Z. Ai, MD, PhD, assistant clinical professor, Department of Medicine, University of California San Francisco, discusses the scenarios in which she has seen the most benefit from brentuximab vedotin (Adcetris) in patients with advanced stage cutaneous T-cell lymphoma (CTCL).

Visa mer
0 Kommentarer sort Sortera efter
Facebook-kommentarer

Strax

Autospela